Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | CRHBP | P24387 | 1/20 | 0.42 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.42 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29795690 | 0.87 | KDM4E (0.66) | GAASMN1; SMN2ALDH1A1KDM4EHSD17B10 | |
| SCHEMBL11489099 | 0.86 | KDM4E (0.53) | GAASMN1; SMN2ALDH1A1KDM4EHSD17B10 | |
| SCHEMBL10461860 | 0.86 | ALDH1A1 (0.60) | GAASMN1; SMN2ALDH1A1KDM4EHSD17B10 | |
| SCHEMBL5027025 | 0.84 | KDM4E (0.41) | GAASMN1; SMN2ALDH1A1KDM4EHSD17B10 | |
| SCHEMBL2229192 | 0.82 | GAA (0.71) | GAASMN1; SMN2ALDH1A1KDM4EHSD17B10 | |
| SCHEMBL4098277 | 0.81 | CYP1A2 (0.53) | GAASMN1; SMN2ALDH1A1KDM4EHSD17B10 | |
| SCHEMBL16616673 | 0.80 | KDM4E (0.72) | GAASMN1; SMN2ALDH1A1KDM4EHSD17B10 | |
| SCHEMBL14190689 | 0.79 | SMN1; SMN2 (0.47) | GAASMN1; SMN2ALDH1A1KDM4EHSD17B10 | |
| SCHEMBL31030218 | 0.79 | L3MBTL1 (0.68) | GAASMN1; SMN2ALDH1A1KDM4EHSD17B10 | |
| SCHEMBL31030177 | 0.78 | GAA (0.43) | GAASMN1; SMN2ALDH1A1KDM4EHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114401963-B | Pesticidally active cyclic amine compounds | 先正达农作物保护股份公司 | 2025-03-14 | — | — | CN | disclosed |
| US-20220389000-A1 | PESTICIDALLY ACTIVE CYCLIC AMINE COMPOUNDS | SYNGENTA CROP PROTECTION AG (CH) | 2022-12-08 | — | — | US | disclosed |
| US-20220389000-A1 | PESTICIDALLY ACTIVE CYCLIC AMINE COMPOUNDS | SYNGENTA CROP PROTECTION AG (CH) | 2022-12-08 | — | — | US | disclosed |
| EP-4031545-A1 | PESTICIDALLY ACTIVE CYCLIC AMINE COMPOUNDS | Syngenta Crop Protection AG (CH) | 2022-07-27 | — | — | EP | disclosed |
| CN-114401963-A | Pesticidally active cyclic amine compounds | 先正达农作物保护股份公司 | 2022-04-26 | — | — | CN | disclosed |
| WO-2021053161-A1 | PESTICIDALLY ACTIVE CYCLIC AMINE COMPOUNDS | SYNGENTA CROP PROTECTION AG (CH) | 2021-03-25 | — | — | WO | disclosed |
| WO-2021053161-A1 | PESTICIDALLY ACTIVE CYCLIC AMINE COMPOUNDS | SYNGENTA CROP PROTECTION AG (CH) | 2021-03-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220389000-A1 | PESTICIDALLY ACTIVE CYCLIC AMINE COMPOUNDS | DDT, ACHE, PNMT | GAA 3455/4885SMN1; SMN2 852/4885ALDH1A1 1079/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.